BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

41 related articles for article (PubMed ID: 31287606)

  • 1. Folding and Binding Kinetics of the Tandem of SH2 Domains from SHP2.
    Pagano L; Pennacchietti V; Malagrinò F; Di Felice M; Toso J; Puglisi E; Gianni S; Toto A
    Int J Mol Sci; 2024 Jun; 25(12):. PubMed ID: 38928272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural Determinants of Phosphopeptide Binding to the N-Terminal Src Homology 2 Domain of the SHP2 Phosphatase.
    Anselmi M; Calligari P; Hub JS; Tartaglia M; Bocchinfuso G; Stella L
    J Chem Inf Model; 2020 Jun; 60(6):3157-3171. PubMed ID: 32395997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phi-value analysis of a three-state protein folding pathway by NMR relaxation dispersion spectroscopy.
    Neudecker P; Zarrine-Afsar A; Davidson AR; Kay LE
    Proc Natl Acad Sci U S A; 2007 Oct; 104(40):15717-22. PubMed ID: 17898173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discriminating between competing models for the allosteric regulation of oncogenic phosphatase SHP2 by characterizing its active state.
    Calligari P; Santucci V; Stella L; Bocchinfuso G
    Comput Struct Biotechnol J; 2021; 19():6125-6139. PubMed ID: 34900129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reconstitution of a native-like SH2 domain from disordered peptide fragments examined by multidimensional heteronuclear NMR.
    Ojennus DD; Fleissner MR; Wuttke DS
    Protein Sci; 2001 Nov; 10(11):2162-75. PubMed ID: 11604523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. From covalent transition states in chemistry to noncovalent in biology: from
    Fersht AR
    Q Rev Biophys; 2024 Mar; 57():e4. PubMed ID: 38597675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphopeptide binding to the N-SH2 domain of tyrosine phosphatase SHP2 correlates with the unzipping of its central β-sheet.
    Marasco M; Kirkpatrick J; Carlomagno T; Hub JS; Anselmi M
    Comput Struct Biotechnol J; 2024 Dec; 23():1169-1180. PubMed ID: 38510972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Mechanism of Folding of Human Frataxin in Comparison to the Yeast Homologue - Broad Energy Barriers and the General Properties of the Transition State.
    Pietrangeli P; Marcocci L; Pennacchietti V; Diop A; Di Felice M; Pagano L; Malagrinò F; Toto A; Brunori M; Gianni S
    J Mol Biol; 2024 May; 436(10):168555. PubMed ID: 38552947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of promising inhibitors for N-SH2 domain of SHP2 tyrosine phosphatase: an in silico study.
    Gencer Akçok EB; Güner H; Akçok İ
    Mol Divers; 2024 May; ():. PubMed ID: 38739228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of Hydrodynamic Interactions on the Kinetic Pathway of Protein Folding.
    Yuan J; Tanaka H
    Phys Rev Lett; 2024 Mar; 132(13):138402. PubMed ID: 38613272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Towards a structural and functional analysis of the immunoglobulin-fold proteome.
    Tawfeeq C; Song J; Khaniya U; Madej T; Wang J; Youkharibache P; Abrol R
    Adv Protein Chem Struct Biol; 2024; 138():135-178. PubMed ID: 38220423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An intramolecular energetic network regulates ligand recognition in a SH2 domain.
    Nardella C; Pagano L; Pennacchietti V; Felice MD; Matteo SD; Diop A; Malagrinò F; Marcocci L; Pietrangeli P; Gianni S; Toto A
    Protein Sci; 2023 Aug; 32(8):e4729. PubMed ID: 37468946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SH2 Domains: Folding, Binding and Therapeutical Approaches.
    Diop A; Santorelli D; Malagrinò F; Nardella C; Pennacchietti V; Pagano L; Marcocci L; Pietrangeli P; Gianni S; Toto A
    Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determining folding and binding properties of the C-terminal SH2 domain of SHP2.
    Nardella C; Malagrinò F; Pagano L; Rinaldo S; Gianni S; Toto A
    Protein Sci; 2021 Dec; 30(12):2385-2395. PubMed ID: 34605082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Understanding the Mechanism of Recognition of Gab2 by the N-SH2 Domain of SHP2.
    Visconti L; Malagrinò F; Pagano L; Toto A
    Life (Basel); 2020 Jun; 10(6):. PubMed ID: 32545165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unveiling the Molecular Basis of the Noonan Syndrome-Causing Mutation T42A of SHP2.
    Toto A; Malagrinò F; Visconti L; Troilo F; Gianni S
    Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31936901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural characterization of an on-pathway intermediate and transition state in the folding of the N-terminal SH2 domain from SHP2.
    Visconti L; Malagrinò F; Gianni S; Toto A
    FEBS J; 2019 Dec; 286(23):4769-4777. PubMed ID: 31287606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of early and late transition states of the folding pathway of a SH2 domain.
    Toto A; Malagrinò F; Nardella C; Pennacchietti V; Pagano L; Santorelli D; Diop A; Gianni S
    Protein Sci; 2022 Jun; 31(6):e4332. PubMed ID: 35634781
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.